Position in BMY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$548,254
-$31,741 QoQ
Shares Held
9,515
-0.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#1,477
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 41%
Shared 0%
None 59%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Estabrook Capital Management holds $58,767,979 across 13 Drug Manufacturers - General names. BMY ranks #7 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
89,720 | $22,786,188 | |
| 2 | MRK |
Merck & Co., Inc.
|
96,811 | $12,440,213 | |
| 3 | PFE |
Pfizer Inc
|
324,099 | $7,804,303 | |
| 4 | AMGN |
Amgen Inc
|
18,721 | $6,779,248 | |
| 5 | LLY |
ELI LILLY & Co
|
3,705 | $4,443,888 | |
| 6 | ABBV |
AbbVie Inc.
|
12,861 | $3,236,342 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
9,515 | $548,254 | |
| 8 | BIIB |
Biogen Inc.
|
2,000 | $432,120 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $548,254 | 9,515 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $579,995 | 9,563 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $522,840 | 9,693 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $451,315 | 10,007 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $517,475 | 11,179 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $694,981 | 11,395 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $644,501 | 11,395 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $610,273 | 11,795 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $512,687 | 12,345 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $672,180 | 12,395 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $800,179 | 15,595 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $908,151 | 15,647 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,000,625 | 15,647 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,112,217 | 16,047 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,154,581 | 16,047 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,161,041 | 16,332 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,288,364 | 16,732 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,228,510 | 16,822 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,064,938 | 17,080 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,010,623 | 17,080 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,194,741 | 17,880 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,138,233 | 18,030 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,127,705 | 18,180 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,096,072 | 18,180 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,068,984 | 18,180 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,108,111 | 19,880 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||